nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—CYP11A1—corpus luteum—testicular cancer	0.105	0.252	CbGeAlD
Mitotane—CYP11A1—seminiferous tubule of testis—testicular cancer	0.0893	0.214	CbGeAlD
Mitotane—SHBG—seminiferous tubule of testis—testicular cancer	0.0716	0.171	CbGeAlD
Mitotane—SHBG—semen—testicular cancer	0.0396	0.0946	CbGeAlD
Mitotane—FDX1—seminal vesicle—testicular cancer	0.023	0.0551	CbGeAlD
Mitotane—FDX1—gonad—testicular cancer	0.0167	0.0398	CbGeAlD
Mitotane—FDX1—female gonad—testicular cancer	0.0135	0.0324	CbGeAlD
Mitotane—FDX1—testis—testicular cancer	0.012	0.0287	CbGeAlD
Mitotane—FDX1—lymph node—testicular cancer	0.0087	0.0208	CbGeAlD
Mitotane—CYP11A1—gonad—testicular cancer	0.00757	0.0181	CbGeAlD
Mitotane—CYP11A1—female gonad—testicular cancer	0.00615	0.0147	CbGeAlD
Mitotane—SHBG—gonad—testicular cancer	0.00606	0.0145	CbGeAlD
Mitotane—CYP11A1—testis—testicular cancer	0.00545	0.013	CbGeAlD
Mitotane—SHBG—female gonad—testicular cancer	0.00493	0.0118	CbGeAlD
Mitotane—SHBG—testis—testicular cancer	0.00437	0.0104	CbGeAlD
Mitotane—CYP11A1—lymph node—testicular cancer	0.00395	0.00945	CbGeAlD
Mitotane—Tremor—Cisplatin—testicular cancer	0.000854	0.00147	CcSEcCtD
Mitotane—Lethargy—Methotrexate—testicular cancer	0.000848	0.00146	CcSEcCtD
Mitotane—Nervous system disorder—Ifosfamide—testicular cancer	0.000846	0.00146	CcSEcCtD
Mitotane—Thrombocytopenia—Ifosfamide—testicular cancer	0.000845	0.00145	CcSEcCtD
Mitotane—Anaemia—Cisplatin—testicular cancer	0.000843	0.00145	CcSEcCtD
Mitotane—Skin disorder—Ifosfamide—testicular cancer	0.000838	0.00144	CcSEcCtD
Mitotane—Feeling abnormal—Bleomycin—testicular cancer	0.000832	0.00143	CcSEcCtD
Mitotane—Osteoarthritis—Methotrexate—testicular cancer	0.000831	0.00143	CcSEcCtD
Mitotane—Vomiting—Chlorambucil—testicular cancer	0.00083	0.00143	CcSEcCtD
Mitotane—Anorexia—Ifosfamide—testicular cancer	0.000823	0.00141	CcSEcCtD
Mitotane—Decreased appetite—Dactinomycin—testicular cancer	0.000819	0.00141	CcSEcCtD
Mitotane—Diarrhoea—Vinblastine—testicular cancer	0.000818	0.00141	CcSEcCtD
Mitotane—Dysgeusia—Etoposide—testicular cancer	0.000818	0.00141	CcSEcCtD
Mitotane—Hypotension—Ifosfamide—testicular cancer	0.000807	0.00139	CcSEcCtD
Mitotane—Pain—Dactinomycin—testicular cancer	0.000805	0.00138	CcSEcCtD
Mitotane—Body temperature increased—Bleomycin—testicular cancer	0.000798	0.00137	CcSEcCtD
Mitotane—Lethargy—Epirubicin—testicular cancer	0.000793	0.00136	CcSEcCtD
Mitotane—Irritability—Methotrexate—testicular cancer	0.000793	0.00136	CcSEcCtD
Mitotane—Dizziness—Vinblastine—testicular cancer	0.000791	0.00136	CcSEcCtD
Mitotane—Ataxia—Methotrexate—testicular cancer	0.000781	0.00134	CcSEcCtD
Mitotane—Osteoarthritis—Epirubicin—testicular cancer	0.000777	0.00134	CcSEcCtD
Mitotane—Diplopia—Epirubicin—testicular cancer	0.000777	0.00134	CcSEcCtD
Mitotane—Feeling abnormal—Dactinomycin—testicular cancer	0.000776	0.00133	CcSEcCtD
Mitotane—Nausea—Chlorambucil—testicular cancer	0.000775	0.00133	CcSEcCtD
Mitotane—Paraesthesia—Ifosfamide—testicular cancer	0.000775	0.00133	CcSEcCtD
Mitotane—Anaemia—Etoposide—testicular cancer	0.000772	0.00133	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000771	0.00133	CcSEcCtD
Mitotane—Somnolence—Ifosfamide—testicular cancer	0.000767	0.00132	CcSEcCtD
Mitotane—Vomiting—Vinblastine—testicular cancer	0.00076	0.00131	CcSEcCtD
Mitotane—Breast disorder—Methotrexate—testicular cancer	0.000751	0.00129	CcSEcCtD
Mitotane—Vertigo—Etoposide—testicular cancer	0.00075	0.00129	CcSEcCtD
Mitotane—Decreased appetite—Ifosfamide—testicular cancer	0.00075	0.00129	CcSEcCtD
Mitotane—Headache—Vinblastine—testicular cancer	0.000749	0.00129	CcSEcCtD
Mitotane—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000745	0.00128	CcSEcCtD
Mitotane—Body temperature increased—Dactinomycin—testicular cancer	0.000745	0.00128	CcSEcCtD
Mitotane—Hypersensitivity—Bleomycin—testicular cancer	0.000744	0.00128	CcSEcCtD
Mitotane—Infection—Cisplatin—testicular cancer	0.000739	0.00127	CcSEcCtD
Mitotane—Pain—Ifosfamide—testicular cancer	0.000738	0.00127	CcSEcCtD
Mitotane—Lethargy—Doxorubicin—testicular cancer	0.000734	0.00126	CcSEcCtD
Mitotane—Ataxia—Epirubicin—testicular cancer	0.000731	0.00126	CcSEcCtD
Mitotane—Nervous system disorder—Cisplatin—testicular cancer	0.00073	0.00125	CcSEcCtD
Mitotane—Thrombocytopenia—Cisplatin—testicular cancer	0.000729	0.00125	CcSEcCtD
Mitotane—Asthenia—Bleomycin—testicular cancer	0.000725	0.00125	CcSEcCtD
Mitotane—Skin disorder—Cisplatin—testicular cancer	0.000723	0.00124	CcSEcCtD
Mitotane—Hypertension—Etoposide—testicular cancer	0.000721	0.00124	CcSEcCtD
Mitotane—Osteoarthritis—Doxorubicin—testicular cancer	0.000719	0.00124	CcSEcCtD
Mitotane—Diplopia—Doxorubicin—testicular cancer	0.000719	0.00124	CcSEcCtD
Mitotane—Feeling abnormal—Ifosfamide—testicular cancer	0.000711	0.00122	CcSEcCtD
Mitotane—Nausea—Vinblastine—testicular cancer	0.00071	0.00122	CcSEcCtD
Mitotane—Orthostatic hypotension—Epirubicin—testicular cancer	0.00071	0.00122	CcSEcCtD
Mitotane—Anorexia—Cisplatin—testicular cancer	0.000709	0.00122	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000706	0.00121	CcSEcCtD
Mitotane—Breast disorder—Epirubicin—testicular cancer	0.000703	0.00121	CcSEcCtD
Mitotane—Hypotension—Cisplatin—testicular cancer	0.000695	0.0012	CcSEcCtD
Mitotane—Hypersensitivity—Dactinomycin—testicular cancer	0.000694	0.00119	CcSEcCtD
Mitotane—Confusional state—Etoposide—testicular cancer	0.000687	0.00118	CcSEcCtD
Mitotane—Muscular weakness—Epirubicin—testicular cancer	0.000686	0.00118	CcSEcCtD
Mitotane—Body temperature increased—Ifosfamide—testicular cancer	0.000682	0.00117	CcSEcCtD
Mitotane—Infection—Etoposide—testicular cancer	0.000677	0.00116	CcSEcCtD
Mitotane—Ataxia—Doxorubicin—testicular cancer	0.000676	0.00116	CcSEcCtD
Mitotane—Asthenia—Dactinomycin—testicular cancer	0.000676	0.00116	CcSEcCtD
Mitotane—Neutropenia—Methotrexate—testicular cancer	0.000671	0.00115	CcSEcCtD
Mitotane—Paraesthesia—Cisplatin—testicular cancer	0.000668	0.00115	CcSEcCtD
Mitotane—Thrombocytopenia—Etoposide—testicular cancer	0.000667	0.00115	CcSEcCtD
Mitotane—Skin disorder—Etoposide—testicular cancer	0.000662	0.00114	CcSEcCtD
Mitotane—Orthostatic hypotension—Doxorubicin—testicular cancer	0.000657	0.00113	CcSEcCtD
Mitotane—Breast disorder—Doxorubicin—testicular cancer	0.00065	0.00112	CcSEcCtD
Mitotane—Anorexia—Etoposide—testicular cancer	0.00065	0.00112	CcSEcCtD
Mitotane—Decreased appetite—Cisplatin—testicular cancer	0.000647	0.00111	CcSEcCtD
Mitotane—Diarrhoea—Dactinomycin—testicular cancer	0.000644	0.00111	CcSEcCtD
Mitotane—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000642	0.0011	CcSEcCtD
Mitotane—Vomiting—Bleomycin—testicular cancer	0.000642	0.0011	CcSEcCtD
Mitotane—Drowsiness—Methotrexate—testicular cancer	0.00064	0.0011	CcSEcCtD
Mitotane—Infestation NOS—Methotrexate—testicular cancer	0.00064	0.0011	CcSEcCtD
Mitotane—Infestation—Methotrexate—testicular cancer	0.00064	0.0011	CcSEcCtD
Mitotane—Hypotension—Etoposide—testicular cancer	0.000637	0.0011	CcSEcCtD
Mitotane—Rash—Bleomycin—testicular cancer	0.000637	0.00109	CcSEcCtD
Mitotane—Pain—Cisplatin—testicular cancer	0.000636	0.00109	CcSEcCtD
Mitotane—Dermatitis—Bleomycin—testicular cancer	0.000636	0.00109	CcSEcCtD
Mitotane—Hypersensitivity—Ifosfamide—testicular cancer	0.000636	0.00109	CcSEcCtD
Mitotane—Muscular weakness—Doxorubicin—testicular cancer	0.000634	0.00109	CcSEcCtD
Mitotane—Neutropenia—Epirubicin—testicular cancer	0.000628	0.00108	CcSEcCtD
Mitotane—Asthenia—Ifosfamide—testicular cancer	0.000619	0.00106	CcSEcCtD
Mitotane—Feeling abnormal—Cisplatin—testicular cancer	0.000613	0.00105	CcSEcCtD
Mitotane—Paraesthesia—Etoposide—testicular cancer	0.000612	0.00105	CcSEcCtD
Mitotane—Haematuria—Methotrexate—testicular cancer	0.00061	0.00105	CcSEcCtD
Mitotane—Somnolence—Etoposide—testicular cancer	0.000606	0.00104	CcSEcCtD
Mitotane—Hepatobiliary disease—Methotrexate—testicular cancer	0.000606	0.00104	CcSEcCtD
Mitotane—Nausea—Bleomycin—testicular cancer	0.0006	0.00103	CcSEcCtD
Mitotane—Infestation NOS—Epirubicin—testicular cancer	0.000599	0.00103	CcSEcCtD
Mitotane—Drowsiness—Epirubicin—testicular cancer	0.000599	0.00103	CcSEcCtD
Mitotane—Infestation—Epirubicin—testicular cancer	0.000599	0.00103	CcSEcCtD
Mitotane—Vomiting—Dactinomycin—testicular cancer	0.000599	0.00103	CcSEcCtD
Mitotane—Rash—Dactinomycin—testicular cancer	0.000594	0.00102	CcSEcCtD
Mitotane—Decreased appetite—Etoposide—testicular cancer	0.000593	0.00102	CcSEcCtD
Mitotane—Diarrhoea—Ifosfamide—testicular cancer	0.000591	0.00102	CcSEcCtD
Mitotane—Gastrointestinal disorder—Etoposide—testicular cancer	0.000589	0.00101	CcSEcCtD
Mitotane—Body temperature increased—Cisplatin—testicular cancer	0.000588	0.00101	CcSEcCtD
Mitotane—Pain—Etoposide—testicular cancer	0.000583	0.001	CcSEcCtD
Mitotane—Neutropenia—Doxorubicin—testicular cancer	0.000581	0.001	CcSEcCtD
Mitotane—Hepatitis—Methotrexate—testicular cancer	0.000575	0.000988	CcSEcCtD
Mitotane—Haematuria—Epirubicin—testicular cancer	0.000571	0.000982	CcSEcCtD
Mitotane—Dizziness—Ifosfamide—testicular cancer	0.000571	0.000981	CcSEcCtD
Mitotane—Urinary tract disorder—Methotrexate—testicular cancer	0.000568	0.000976	CcSEcCtD
Mitotane—Hepatobiliary disease—Epirubicin—testicular cancer	0.000567	0.000974	CcSEcCtD
Mitotane—Urethral disorder—Methotrexate—testicular cancer	0.000563	0.000969	CcSEcCtD
Mitotane—Feeling abnormal—Etoposide—testicular cancer	0.000562	0.000966	CcSEcCtD
Mitotane—Nausea—Dactinomycin—testicular cancer	0.000559	0.000962	CcSEcCtD
Mitotane—Drowsiness—Doxorubicin—testicular cancer	0.000554	0.000953	CcSEcCtD
Mitotane—Infestation NOS—Doxorubicin—testicular cancer	0.000554	0.000953	CcSEcCtD
Mitotane—Infestation—Doxorubicin—testicular cancer	0.000554	0.000953	CcSEcCtD
Mitotane—Visual impairment—Methotrexate—testicular cancer	0.000554	0.000952	CcSEcCtD
Mitotane—Vomiting—Ifosfamide—testicular cancer	0.000549	0.000944	CcSEcCtD
Mitotane—Hypersensitivity—Cisplatin—testicular cancer	0.000548	0.000943	CcSEcCtD
Mitotane—Rash—Ifosfamide—testicular cancer	0.000544	0.000936	CcSEcCtD
Mitotane—Dermatitis—Ifosfamide—testicular cancer	0.000544	0.000935	CcSEcCtD
Mitotane—Body temperature increased—Etoposide—testicular cancer	0.000539	0.000927	CcSEcCtD
Mitotane—Hepatitis—Epirubicin—testicular cancer	0.000538	0.000925	CcSEcCtD
Mitotane—Eye disorder—Methotrexate—testicular cancer	0.000537	0.000923	CcSEcCtD
Mitotane—Asthenia—Cisplatin—testicular cancer	0.000534	0.000918	CcSEcCtD
Mitotane—Urinary tract disorder—Epirubicin—testicular cancer	0.000531	0.000913	CcSEcCtD
Mitotane—Haematuria—Doxorubicin—testicular cancer	0.000529	0.000909	CcSEcCtD
Mitotane—Connective tissue disorder—Epirubicin—testicular cancer	0.000529	0.000909	CcSEcCtD
Mitotane—Urethral disorder—Epirubicin—testicular cancer	0.000527	0.000906	CcSEcCtD
Mitotane—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000524	0.000901	CcSEcCtD
Mitotane—Angiopathy—Methotrexate—testicular cancer	0.000521	0.000897	CcSEcCtD
Mitotane—Visual impairment—Epirubicin—testicular cancer	0.000518	0.000891	CcSEcCtD
Mitotane—Nausea—Ifosfamide—testicular cancer	0.000513	0.000881	CcSEcCtD
Mitotane—Diarrhoea—Cisplatin—testicular cancer	0.000509	0.000875	CcSEcCtD
Mitotane—Mental disorder—Methotrexate—testicular cancer	0.000504	0.000866	CcSEcCtD
Mitotane—Eye disorder—Epirubicin—testicular cancer	0.000503	0.000864	CcSEcCtD
Mitotane—Hypersensitivity—Etoposide—testicular cancer	0.000502	0.000864	CcSEcCtD
Mitotane—Malnutrition—Methotrexate—testicular cancer	0.0005	0.00086	CcSEcCtD
Mitotane—Flushing—Epirubicin—testicular cancer	0.000499	0.000858	CcSEcCtD
Mitotane—Hepatitis—Doxorubicin—testicular cancer	0.000498	0.000856	CcSEcCtD
Mitotane—Urinary tract disorder—Doxorubicin—testicular cancer	0.000491	0.000845	CcSEcCtD
Mitotane—Dysgeusia—Methotrexate—testicular cancer	0.00049	0.000842	CcSEcCtD
Mitotane—Asthenia—Etoposide—testicular cancer	0.000489	0.000841	CcSEcCtD
Mitotane—Connective tissue disorder—Doxorubicin—testicular cancer	0.000489	0.000841	CcSEcCtD
Mitotane—Angiopathy—Epirubicin—testicular cancer	0.000488	0.000839	CcSEcCtD
Mitotane—Urethral disorder—Doxorubicin—testicular cancer	0.000488	0.000839	CcSEcCtD
Mitotane—Visual impairment—Doxorubicin—testicular cancer	0.00048	0.000825	CcSEcCtD
Mitotane—Vomiting—Cisplatin—testicular cancer	0.000473	0.000813	CcSEcCtD
Mitotane—Vision blurred—Methotrexate—testicular cancer	0.000472	0.000811	CcSEcCtD
Mitotane—Mental disorder—Epirubicin—testicular cancer	0.000471	0.00081	CcSEcCtD
Mitotane—Rash—Cisplatin—testicular cancer	0.000469	0.000807	CcSEcCtD
Mitotane—Dermatitis—Cisplatin—testicular cancer	0.000469	0.000806	CcSEcCtD
Mitotane—Malnutrition—Epirubicin—testicular cancer	0.000468	0.000805	CcSEcCtD
Mitotane—Diarrhoea—Etoposide—testicular cancer	0.000466	0.000802	CcSEcCtD
Mitotane—Eye disorder—Doxorubicin—testicular cancer	0.000465	0.0008	CcSEcCtD
Mitotane—Anaemia—Methotrexate—testicular cancer	0.000462	0.000795	CcSEcCtD
Mitotane—Flushing—Doxorubicin—testicular cancer	0.000462	0.000794	CcSEcCtD
Mitotane—Dysgeusia—Epirubicin—testicular cancer	0.000459	0.000788	CcSEcCtD
Mitotane—Angiopathy—Doxorubicin—testicular cancer	0.000452	0.000776	CcSEcCtD
Mitotane—Dizziness—Etoposide—testicular cancer	0.000451	0.000775	CcSEcCtD
Mitotane—Vertigo—Methotrexate—testicular cancer	0.00045	0.000773	CcSEcCtD
Mitotane—Nausea—Cisplatin—testicular cancer	0.000442	0.00076	CcSEcCtD
Mitotane—Vision blurred—Epirubicin—testicular cancer	0.000441	0.000759	CcSEcCtD
Mitotane—Mental disorder—Doxorubicin—testicular cancer	0.000436	0.00075	CcSEcCtD
Mitotane—Vomiting—Etoposide—testicular cancer	0.000433	0.000745	CcSEcCtD
Mitotane—Malnutrition—Doxorubicin—testicular cancer	0.000433	0.000745	CcSEcCtD
Mitotane—Anaemia—Epirubicin—testicular cancer	0.000433	0.000744	CcSEcCtD
Mitotane—Rash—Etoposide—testicular cancer	0.00043	0.000739	CcSEcCtD
Mitotane—Dermatitis—Etoposide—testicular cancer	0.000429	0.000738	CcSEcCtD
Mitotane—Headache—Etoposide—testicular cancer	0.000427	0.000734	CcSEcCtD
Mitotane—Dysgeusia—Doxorubicin—testicular cancer	0.000424	0.000729	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000423	0.000727	CcSEcCtD
Mitotane—Vertigo—Epirubicin—testicular cancer	0.000421	0.000723	CcSEcCtD
Mitotane—Confusional state—Methotrexate—testicular cancer	0.000412	0.000708	CcSEcCtD
Mitotane—Vision blurred—Doxorubicin—testicular cancer	0.000408	0.000702	CcSEcCtD
Mitotane—Infection—Methotrexate—testicular cancer	0.000406	0.000697	CcSEcCtD
Mitotane—Nausea—Etoposide—testicular cancer	0.000405	0.000696	CcSEcCtD
Mitotane—Hypertension—Epirubicin—testicular cancer	0.000404	0.000695	CcSEcCtD
Mitotane—Nervous system disorder—Methotrexate—testicular cancer	0.0004	0.000688	CcSEcCtD
Mitotane—Anaemia—Doxorubicin—testicular cancer	0.0004	0.000688	CcSEcCtD
Mitotane—Thrombocytopenia—Methotrexate—testicular cancer	0.0004	0.000687	CcSEcCtD
Mitotane—Skin disorder—Methotrexate—testicular cancer	0.000397	0.000682	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000396	0.000681	CcSEcCtD
Mitotane—Vertigo—Doxorubicin—testicular cancer	0.000389	0.000669	CcSEcCtD
Mitotane—Anorexia—Methotrexate—testicular cancer	0.000389	0.000669	CcSEcCtD
Mitotane—Confusional state—Epirubicin—testicular cancer	0.000385	0.000662	CcSEcCtD
Mitotane—Hypotension—Methotrexate—testicular cancer	0.000382	0.000656	CcSEcCtD
Mitotane—Infection—Epirubicin—testicular cancer	0.00038	0.000653	CcSEcCtD
Mitotane—Shock—Epirubicin—testicular cancer	0.000376	0.000646	CcSEcCtD
Mitotane—Nervous system disorder—Epirubicin—testicular cancer	0.000375	0.000644	CcSEcCtD
Mitotane—Thrombocytopenia—Epirubicin—testicular cancer	0.000374	0.000643	CcSEcCtD
Mitotane—Hypertension—Doxorubicin—testicular cancer	0.000374	0.000643	CcSEcCtD
Mitotane—Skin disorder—Epirubicin—testicular cancer	0.000371	0.000638	CcSEcCtD
Mitotane—Paraesthesia—Methotrexate—testicular cancer	0.000367	0.00063	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000366	0.00063	CcSEcCtD
Mitotane—Anorexia—Epirubicin—testicular cancer	0.000364	0.000626	CcSEcCtD
Mitotane—Somnolence—Methotrexate—testicular cancer	0.000363	0.000624	CcSEcCtD
Mitotane—Dyspepsia—Methotrexate—testicular cancer	0.000359	0.000618	CcSEcCtD
Mitotane—Hypotension—Epirubicin—testicular cancer	0.000357	0.000614	CcSEcCtD
Mitotane—Confusional state—Doxorubicin—testicular cancer	0.000357	0.000613	CcSEcCtD
Mitotane—Decreased appetite—Methotrexate—testicular cancer	0.000355	0.00061	CcSEcCtD
Mitotane—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000353	0.000606	CcSEcCtD
Mitotane—Infection—Doxorubicin—testicular cancer	0.000351	0.000604	CcSEcCtD
Mitotane—Pain—Methotrexate—testicular cancer	0.000349	0.0006	CcSEcCtD
Mitotane—Shock—Doxorubicin—testicular cancer	0.000348	0.000598	CcSEcCtD
Mitotane—Nervous system disorder—Doxorubicin—testicular cancer	0.000347	0.000596	CcSEcCtD
Mitotane—Thrombocytopenia—Doxorubicin—testicular cancer	0.000346	0.000595	CcSEcCtD
Mitotane—Skin disorder—Doxorubicin—testicular cancer	0.000343	0.00059	CcSEcCtD
Mitotane—Paraesthesia—Epirubicin—testicular cancer	0.000343	0.00059	CcSEcCtD
Mitotane—Somnolence—Epirubicin—testicular cancer	0.00034	0.000584	CcSEcCtD
Mitotane—Anorexia—Doxorubicin—testicular cancer	0.000337	0.000579	CcSEcCtD
Mitotane—Feeling abnormal—Methotrexate—testicular cancer	0.000336	0.000579	CcSEcCtD
Mitotane—Dyspepsia—Epirubicin—testicular cancer	0.000336	0.000578	CcSEcCtD
Mitotane—Decreased appetite—Epirubicin—testicular cancer	0.000332	0.000571	CcSEcCtD
Mitotane—Hypotension—Doxorubicin—testicular cancer	0.00033	0.000568	CcSEcCtD
Mitotane—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00033	0.000567	CcSEcCtD
Mitotane—Pain—Epirubicin—testicular cancer	0.000327	0.000562	CcSEcCtD
Mitotane—Body temperature increased—Methotrexate—testicular cancer	0.000323	0.000555	CcSEcCtD
Mitotane—Paraesthesia—Doxorubicin—testicular cancer	0.000317	0.000546	CcSEcCtD
Mitotane—Feeling abnormal—Epirubicin—testicular cancer	0.000315	0.000541	CcSEcCtD
Mitotane—Somnolence—Doxorubicin—testicular cancer	0.000314	0.00054	CcSEcCtD
Mitotane—Dyspepsia—Doxorubicin—testicular cancer	0.000311	0.000535	CcSEcCtD
Mitotane—Decreased appetite—Doxorubicin—testicular cancer	0.000307	0.000528	CcSEcCtD
Mitotane—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000305	0.000525	CcSEcCtD
Mitotane—Pain—Doxorubicin—testicular cancer	0.000302	0.00052	CcSEcCtD
Mitotane—Body temperature increased—Epirubicin—testicular cancer	0.000302	0.000519	CcSEcCtD
Mitotane—Hypersensitivity—Methotrexate—testicular cancer	0.000301	0.000517	CcSEcCtD
Mitotane—Asthenia—Methotrexate—testicular cancer	0.000293	0.000504	CcSEcCtD
Mitotane—Feeling abnormal—Doxorubicin—testicular cancer	0.000291	0.000501	CcSEcCtD
Mitotane—Hypersensitivity—Epirubicin—testicular cancer	0.000282	0.000484	CcSEcCtD
Mitotane—Body temperature increased—Doxorubicin—testicular cancer	0.00028	0.000481	CcSEcCtD
Mitotane—Diarrhoea—Methotrexate—testicular cancer	0.000279	0.00048	CcSEcCtD
Mitotane—Asthenia—Epirubicin—testicular cancer	0.000274	0.000471	CcSEcCtD
Mitotane—Dizziness—Methotrexate—testicular cancer	0.00027	0.000464	CcSEcCtD
Mitotane—Diarrhoea—Epirubicin—testicular cancer	0.000261	0.00045	CcSEcCtD
Mitotane—Hypersensitivity—Doxorubicin—testicular cancer	0.000261	0.000448	CcSEcCtD
Mitotane—Vomiting—Methotrexate—testicular cancer	0.00026	0.000446	CcSEcCtD
Mitotane—Rash—Methotrexate—testicular cancer	0.000257	0.000443	CcSEcCtD
Mitotane—Dermatitis—Methotrexate—testicular cancer	0.000257	0.000442	CcSEcCtD
Mitotane—Headache—Methotrexate—testicular cancer	0.000256	0.00044	CcSEcCtD
Mitotane—Asthenia—Doxorubicin—testicular cancer	0.000254	0.000436	CcSEcCtD
Mitotane—Dizziness—Epirubicin—testicular cancer	0.000253	0.000434	CcSEcCtD
Mitotane—Vomiting—Epirubicin—testicular cancer	0.000243	0.000418	CcSEcCtD
Mitotane—Nausea—Methotrexate—testicular cancer	0.000243	0.000417	CcSEcCtD
Mitotane—Diarrhoea—Doxorubicin—testicular cancer	0.000242	0.000416	CcSEcCtD
Mitotane—Rash—Epirubicin—testicular cancer	0.000241	0.000414	CcSEcCtD
Mitotane—Dermatitis—Epirubicin—testicular cancer	0.000241	0.000414	CcSEcCtD
Mitotane—Headache—Epirubicin—testicular cancer	0.000239	0.000412	CcSEcCtD
Mitotane—Dizziness—Doxorubicin—testicular cancer	0.000234	0.000402	CcSEcCtD
Mitotane—Nausea—Epirubicin—testicular cancer	0.000227	0.00039	CcSEcCtD
Mitotane—Vomiting—Doxorubicin—testicular cancer	0.000225	0.000387	CcSEcCtD
Mitotane—Rash—Doxorubicin—testicular cancer	0.000223	0.000383	CcSEcCtD
Mitotane—Dermatitis—Doxorubicin—testicular cancer	0.000223	0.000383	CcSEcCtD
Mitotane—Headache—Doxorubicin—testicular cancer	0.000222	0.000381	CcSEcCtD
Mitotane—Nausea—Doxorubicin—testicular cancer	0.00021	0.000361	CcSEcCtD
